Clinical trial Recruiting at 8 sites Interventional Ages 18 and up

Decision tool for people considering breast reconstruction surgery.

Official title: Breast Reconstruction Decision Aid (RECONJOINT)

Run by Memorial Sloan Kettering Cancer Center · NCT07335354 · Data updated 2026-11-12

Researchers will try a decision tool called RECONJOINT to help adults with breast cancer or a genetic predisposition decide about post-mastectomy breast reconstruction.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment131 (estimated)
SponsorMemorial Sloan Kettering Cancer Center
Academic / other
Locations9 sites (Basking Ridge, New Jersey and 8 other locations)
StatusRecruiting
StartedJanuary 5, 2026
Main results expectedJanuary 5, 2029
Study endsJanuary 5, 2029
Registry record updatedJuly 9, 2026
Trial IDNCT07335354 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with breast cancer or a known genetic predisposition who are considering post-mastectomy breast reconstruction and have a plastic surgery consultation scheduled are ideal candidates.

Probably not a fit

People who are not considering post-mastectomy reconstruction or who cannot participate in English are unlikely to receive benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a feasibility project using the RECONJOINT decision aid with both focus groups and a small randomized pilot to determine if a larger trial is practical. Adult patients with a diagnosis of breast cancer or a genetic predisposition who are considering post-mastectomy reconstruction and have a scheduled plastic surgery consultation are eligible to participate. The study will enroll patient focus groups and randomize eligible patients to receive the decision aid versus usual care, tracking recruitment, retention, acceptability, and preliminary decision-related outcomes. Plastic surgeons who perform breast reconstruction frequently will also be enrolled to gather clinician perspectives on using the tool.

Why it matters

Potential benefit: If successful, the tool could help people better understand reconstruction options and feel more confident and satisfied with their decisions.

How similar studies have gone: Decision aids for surgical choices, including some work in breast reconstruction, have improved patient knowledge and reduced decisional conflict, although RECONJOINT itself is being tested here for feasibility.

Who can join: the full rules

Show full inclusion / exclusion criteria
Participant Inclusion Criteria

Focus Group Participants

* A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
* ≥18 years old
* Considering post-mastectomy breast reconstruction

RCT Participants (Patients)

* A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
* ≥18 years old
* Considering post-mastectomy breast reconstruction
* Have an appointment scheduled for consultation with a plastic surgery provider

RCT Participants (Physicians)

* Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery.

Participant Exclusion Criteria

Focus Group Participants

* Not considering post-mastectomy breast reconstruction
* Non-English proficiency

RCT Participants (Patients)

* Not considering postmastectomy breast reconstruction
* Recurrent or metastatic breast cancer
* Male sex
* Non-English proficiency

RCT Participants (Physicians)

* Does not provide breast reconstruction care at least 50% of the time
* Non-English proficiency

Where it's running

  • Memorial Sloan Kettering Basking Ridge
    Basking Ridge, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Monmouth
    Middletown, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Bergen
    Montvale, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Commack
    Commack, New York, United States
    Recruiting
  • Memorial Sloan Kettering Westchester
    Harrison, New York, United States
    Recruiting
  • Memorial Sloan Kettering Cancer Center
    New York, New York, United States
    Recruiting
Show 3 more locations
  • Memorial Sloan Kettering Nassau
    Rockville Centre, New York, United States
    Recruiting
  • Duke Cancer Institute (Data collection only)
    Durham, North Carolina, United States
    Recruiting
  • Duke Cancer Institute (Data collection only)
    Durham, North Carolina, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Evan Matros, MD — Memorial Sloan Kettering Cancer Center
  • Study coordinator: Evan Matros, MD
  • Email: matrose@mskcc.org
  • Phone: 646-608-8044

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.